Copyright Reports & Markets. All rights reserved.

Global Febrile Neutropenia Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Febrile Neutropenia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Pegfilgrastim
    • 1.2.3 Vancomycin Hydrochloride
    • 1.2.4 Filgrastim Biosimilars
    • 1.2.5 Pegfilgrastim Biosimilars
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Febrile Neutropenia Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Febrile Neutropenia Market Perspective (2016-2027)
  • 2.2 Febrile Neutropenia Growth Trends by Regions
    • 2.2.1 Febrile Neutropenia Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Febrile Neutropenia Historic Market Share by Regions (2016-2021)
    • 2.2.3 Febrile Neutropenia Forecasted Market Size by Regions (2022-2027)
  • 2.3 Febrile Neutropenia Industry Dynamic
    • 2.3.1 Febrile Neutropenia Market Trends
    • 2.3.2 Febrile Neutropenia Market Drivers
    • 2.3.3 Febrile Neutropenia Market Challenges
    • 2.3.4 Febrile Neutropenia Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Febrile Neutropenia Players by Revenue
    • 3.1.1 Global Top Febrile Neutropenia Players by Revenue (2016-2021)
    • 3.1.2 Global Febrile Neutropenia Revenue Market Share by Players (2016-2021)
  • 3.2 Global Febrile Neutropenia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Febrile Neutropenia Revenue
  • 3.4 Global Febrile Neutropenia Market Concentration Ratio
    • 3.4.1 Global Febrile Neutropenia Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Febrile Neutropenia Revenue in 2020
  • 3.5 Febrile Neutropenia Key Players Head office and Area Served
  • 3.6 Key Players Febrile Neutropenia Product Solution and Service
  • 3.7 Date of Enter into Febrile Neutropenia Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Febrile Neutropenia Breakdown Data by Type

  • 4.1 Global Febrile Neutropenia Historic Market Size by Type (2016-2021)
  • 4.2 Global Febrile Neutropenia Forecasted Market Size by Type (2022-2027)

5 Febrile Neutropenia Breakdown Data by Application

  • 5.1 Global Febrile Neutropenia Historic Market Size by Application (2016-2021)
  • 5.2 Global Febrile Neutropenia Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Febrile Neutropenia Market Size (2016-2027)
  • 6.2 North America Febrile Neutropenia Market Size by Type
    • 6.2.1 North America Febrile Neutropenia Market Size by Type (2016-2021)
    • 6.2.2 North America Febrile Neutropenia Market Size by Type (2022-2027)
    • 6.2.3 North America Febrile Neutropenia Market Size by Type (2016-2027)
  • 6.3 North America Febrile Neutropenia Market Size by Application
    • 6.3.1 North America Febrile Neutropenia Market Size by Application (2016-2021)
    • 6.3.2 North America Febrile Neutropenia Market Size by Application (2022-2027)
    • 6.3.3 North America Febrile Neutropenia Market Size by Application (2016-2027)
  • 6.4 North America Febrile Neutropenia Market Size by Country
    • 6.4.1 North America Febrile Neutropenia Market Size by Country (2016-2021)
    • 6.4.2 North America Febrile Neutropenia Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Febrile Neutropenia Market Size (2016-2027)
  • 7.2 Europe Febrile Neutropenia Market Size by Type
    • 7.2.1 Europe Febrile Neutropenia Market Size by Type (2016-2021)
    • 7.2.2 Europe Febrile Neutropenia Market Size by Type (2022-2027)
    • 7.2.3 Europe Febrile Neutropenia Market Size by Type (2016-2027)
  • 7.3 Europe Febrile Neutropenia Market Size by Application
    • 7.3.1 Europe Febrile Neutropenia Market Size by Application (2016-2021)
    • 7.3.2 Europe Febrile Neutropenia Market Size by Application (2022-2027)
    • 7.3.3 Europe Febrile Neutropenia Market Size by Application (2016-2027)
  • 7.4 Europe Febrile Neutropenia Market Size by Country
    • 7.4.1 Europe Febrile Neutropenia Market Size by Country (2016-2021)
    • 7.4.2 Europe Febrile Neutropenia Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Febrile Neutropenia Market Size (2016-2027)
  • 8.2 Asia-Pacific Febrile Neutropenia Market Size by Type
    • 8.2.1 Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Febrile Neutropenia Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Febrile Neutropenia Market Size by Application
    • 8.3.1 Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Febrile Neutropenia Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Febrile Neutropenia Market Size by Region
    • 8.4.1 Asia-Pacific Febrile Neutropenia Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Febrile Neutropenia Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Febrile Neutropenia Market Size (2016-2027)
  • 9.2 Latin America Febrile Neutropenia Market Size by Type
    • 9.2.1 Latin America Febrile Neutropenia Market Size by Type (2016-2021)
    • 9.2.2 Latin America Febrile Neutropenia Market Size by Type (2022-2027)
    • 9.2.3 Latin America Febrile Neutropenia Market Size by Type (2016-2027)
  • 9.3 Latin America Febrile Neutropenia Market Size by Application
    • 9.3.1 Latin America Febrile Neutropenia Market Size by Application (2016-2021)
    • 9.3.2 Latin America Febrile Neutropenia Market Size by Application (2022-2027)
    • 9.3.3 Latin America Febrile Neutropenia Market Size by Application (2016-2027)
  • 9.4 Latin America Febrile Neutropenia Market Size by Country
    • 9.4.1 Latin America Febrile Neutropenia Market Size by Country (2016-2021)
    • 9.4.2 Latin America Febrile Neutropenia Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Febrile Neutropenia Market Size (2016-2027)
  • 10.2 Middle East & Africa Febrile Neutropenia Market Size by Type
    • 10.2.1 Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Febrile Neutropenia Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Febrile Neutropenia Market Size by Application
    • 10.3.1 Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Febrile Neutropenia Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Febrile Neutropenia Market Size by Country
    • 10.4.1 Middle East & Africa Febrile Neutropenia Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Febrile Neutropenia Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Xenetic Biosciences, Inc. (XBIO)
    • 11.1.1 Xenetic Biosciences, Inc. (XBIO) Company Details
    • 11.1.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
    • 11.1.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Introduction
    • 11.1.4 Xenetic Biosciences, Inc. (XBIO) Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.1.5 Xenetic Biosciences, Inc. (XBIO) Recent Development
  • 11.2 Richter Gedeon Nyrt.
    • 11.2.1 Richter Gedeon Nyrt. Company Details
    • 11.2.2 Richter Gedeon Nyrt. Business Overview
    • 11.2.3 Richter Gedeon Nyrt. Febrile Neutropenia Introduction
    • 11.2.4 Richter Gedeon Nyrt. Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.2.5 Richter Gedeon Nyrt. Recent Development
  • 11.3 Amgen Inc.
    • 11.3.1 Amgen Inc. Company Details
    • 11.3.2 Amgen Inc. Business Overview
    • 11.3.3 Amgen Inc. Febrile Neutropenia Introduction
    • 11.3.4 Amgen Inc. Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.3.5 Amgen Inc. Recent Development
  • 11.4 Hospira, Inc.
    • 11.4.1 Hospira, Inc. Company Details
    • 11.4.2 Hospira, Inc. Business Overview
    • 11.4.3 Hospira, Inc. Febrile Neutropenia Introduction
    • 11.4.4 Hospira, Inc. Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.4.5 Hospira, Inc. Recent Development
  • 11.5 Eli Lilly and Company
    • 11.5.1 Eli Lilly and Company Company Details
    • 11.5.2 Eli Lilly and Company Business Overview
    • 11.5.3 Eli Lilly and Company Febrile Neutropenia Introduction
    • 11.5.4 Eli Lilly and Company Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.5.5 Eli Lilly and Company Recent Development
  • 11.6 USV Private Limited
    • 11.6.1 USV Private Limited Company Details
    • 11.6.2 USV Private Limited Business Overview
    • 11.6.3 USV Private Limited Febrile Neutropenia Introduction
    • 11.6.4 USV Private Limited Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.6.5 USV Private Limited Recent Development
  • 11.7 Aequus BioPharma, Inc.
    • 11.7.1 Aequus BioPharma, Inc. Company Details
    • 11.7.2 Aequus BioPharma, Inc. Business Overview
    • 11.7.3 Aequus BioPharma, Inc. Febrile Neutropenia Introduction
    • 11.7.4 Aequus BioPharma, Inc. Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.7.5 Aequus BioPharma, Inc. Recent Development
  • 11.8 Taiho Pharmaceutical Co., Ltd.
    • 11.8.1 Taiho Pharmaceutical Co., Ltd. Company Details
    • 11.8.2 Taiho Pharmaceutical Co., Ltd. Business Overview
    • 11.8.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Introduction
    • 11.8.4 Taiho Pharmaceutical Co., Ltd. Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.8.5 Taiho Pharmaceutical Co., Ltd. Recent Development
  • 11.9 BeyondSpring Inc.
    • 11.9.1 BeyondSpring Inc. Company Details
    • 11.9.2 BeyondSpring Inc. Business Overview
    • 11.9.3 BeyondSpring Inc. Febrile Neutropenia Introduction
    • 11.9.4 BeyondSpring Inc. Revenue in Febrile Neutropenia Business (2016-2021)
    • 11.9.5 BeyondSpring Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Febrile Neutropenia Scope and Market Size
    Febrile Neutropenia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Febrile Neutropenia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Pegfilgrastim
    Vancomycin Hydrochloride
    Filgrastim Biosimilars
    Pegfilgrastim Biosimilars
    Others

    Segment by Application
    Hospitals
    Clinics
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Xenetic Biosciences, Inc. (XBIO)
    Richter Gedeon Nyrt.
    Amgen Inc.
    Hospira, Inc.
    Eli Lilly and Company
    USV Private Limited
    Aequus BioPharma, Inc.
    Taiho Pharmaceutical Co., Ltd.
    BeyondSpring Inc.

    Buy now